APO RESEARCH · REPORT
Sevoflurane
Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.
Product & engineering
Understand the product.
Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.
In this report, one unit is 250 ml Sevoflurane.
Selected research
Industry Research
Sevoflurane Industry Research Report 2026
Market perspective
Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.
In this report, one unit is 250 ml Sevoflurane.
Europe is the largest Sevoflurane market with about 40% market share. Asia is follower, accounting for about 25% market share.
Read the full market overview
The key players are Abbott, Baxter, Maruishi, Jiangsu Hengrui, Lunan etc. Top 3 companies occupied about 63% market share.
Report Scope
This report quantifies the global Sevoflurane market in revenue (US$ million) and, where applicable, sales volume (K t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/K t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Sevoflurane.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sevoflurane Market by Company
Abbott
Baxter
Maruishi
Jiangsu Hengrui
Lunan
Sevoflurane Segment by Type
Generic Drug
Original Drug
Sevoflurane Segment by Application
Hospitals
Other Medical Institutions
Sevoflurane Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sevoflurane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sevoflurane and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sevoflurane.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sevoflurane manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sevoflurane by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sevoflurane in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Generic Drug
- Original Drug
Applications
- Hospitals
- Other Medical Institutions
Companies covered
- Abbott
- Baxter
- Maruishi
- Jiangsu Hengrui
- Lunan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Sevoflurane by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Generic Drug
- 2.2.3 Original Drug
- 2.3 Sevoflurane by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Hospitals
- 2.3.3 Other Medical Institutions
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Sevoflurane Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Sevoflurane Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Sevoflurane Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Sevoflurane Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sevoflurane Production by Manufacturers (2021-2026)
- 3.2 Global Sevoflurane Production Value by Manufacturers (2021-2026)
- 3.3 Global Sevoflurane Average Price by Manufacturers (2021-2026)
- 3.4 Global Sevoflurane Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sevoflurane Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Sevoflurane Manufacturers, Product Type & Application
- 3.7 Global Sevoflurane Manufacturers Established Date
- 3.8 Global Sevoflurane Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Sevoflurane Company Information
- 4.1.2 Abbott Sevoflurane Business Overview
- 4.1.3 Abbott Sevoflurane Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Abbott Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Baxter
- 4.2.1 Baxter Sevoflurane Company Information
- 4.2.2 Baxter Sevoflurane Business Overview
- 4.2.3 Baxter Sevoflurane Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Baxter Product Portfolio
- 4.2.5 Baxter Recent Developments
- 4.3 Maruishi
- 4.3.1 Maruishi Sevoflurane Company Information
- 4.3.2 Maruishi Sevoflurane Business Overview
- 4.3.3 Maruishi Sevoflurane Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Maruishi Product Portfolio
- 4.3.5 Maruishi Recent Developments
- 4.4 Jiangsu Hengrui
- 4.4.1 Jiangsu Hengrui Sevoflurane Company Information
- 4.4.2 Jiangsu Hengrui Sevoflurane Business Overview
- 4.4.3 Jiangsu Hengrui Sevoflurane Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Jiangsu Hengrui Product Portfolio
- 4.4.5 Jiangsu Hengrui Recent Developments
- 4.5 Lunan
- 4.5.1 Lunan Sevoflurane Company Information
- 4.5.2 Lunan Sevoflurane Business Overview
- 4.5.3 Lunan Sevoflurane Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Lunan Product Portfolio
- 4.5.5 Lunan Recent Developments
5 Global Sevoflurane Production by Region
- 5.1 Global Sevoflurane Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sevoflurane Production by Region: 2021-2032
- 5.2.1 Global Sevoflurane Production by Region: 2021-2026
- 5.2.2 Global Sevoflurane Production Forecast by Region (2027-2032)
- 5.3 Global Sevoflurane Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Sevoflurane Production Value by Region: 2021-2032
- 5.4.1 Global Sevoflurane Production Value by Region: 2021-2026
- 5.4.2 Global Sevoflurane Production Value Forecast by Region (2027-2032)
- 5.5 Global Sevoflurane Market Price Analysis by Region (2021-2026)
- 5.6 Global Sevoflurane Production and Value, YOY Growth
- 5.6.1 North America Sevoflurane Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Sevoflurane Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Sevoflurane Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Sevoflurane Production Value Estimates and Forecasts (2021-2032)
6 Global Sevoflurane Consumption by Region
- 6.1 Global Sevoflurane Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sevoflurane Consumption by Region (2021-2032)
- 6.2.1 Global Sevoflurane Consumption by Region: 2021-2026
- 6.2.2 Global Sevoflurane Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sevoflurane Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sevoflurane Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sevoflurane Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Sevoflurane Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Sevoflurane Production by Type (2021-2032)
- 7.1.1 Global Sevoflurane Production by Type (2021-2032) & (K t)
- 7.1.2 Global Sevoflurane Production Market Share by Type (2021-2032)
- 7.2 Global Sevoflurane Production Value by Type (2021-2032)
- 7.2.1 Global Sevoflurane Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Sevoflurane Production Value Market Share by Type (2021-2032)
- 7.3 Global Sevoflurane Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Sevoflurane Production by Application (2021-2032)
- 8.1.1 Global Sevoflurane Production by Application (2021-2032) & (K t)
- 8.1.2 Global Sevoflurane Production Market Share by Application (2021-2032)
- 8.2 Global Sevoflurane Production Value by Application (2021-2032)
- 8.2.1 Global Sevoflurane Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Sevoflurane Production Value Market Share by Application (2021-2032)
- 8.3 Global Sevoflurane Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Sevoflurane Value Chain Analysis
- 9.1.1 Sevoflurane Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Sevoflurane Production Mode & Process
- 9.2 Sevoflurane Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sevoflurane Distributors
- 9.2.3 Sevoflurane Customers
10 Global Sevoflurane Analyzing Market Dynamics
- 10.1 Sevoflurane Industry Trends
- 10.2 Sevoflurane Industry Drivers
- 10.3 Sevoflurane Industry Opportunities and Challenges
- 10.4 Sevoflurane Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst